Jounce Therapeutics Inc (JNCE)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2016 | 06-2016 | 03-2016 | 12-2015 | 12-2014 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -19,169 | -23,239 | -10,890 | -28,532 | 0 |
| Depreciation Amortization | 1,489 | 912 | 447 | 1,470 | 0 |
| Other Working Capital | 205,521 | -2,044 | -1,455 | 1,830 | 0 |
| Other Operating Activity | 3,720 | 1,095 | 440 | -507 | 0 |
| Operating Cash Flow | $191,561 | $-23,276 | $-11,458 | $-25,739 | $0 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | -182,274 | N/A | N/A | N/A | N/A |
| PPE Investments | -1,254 | -634 | -250 | -2,202 | 0 |
| Other Investing Activity | 0 | 0 | 0 | 60 | 0 |
| Investing Cash Flow | $-183,528 | $-634 | $-250 | $-2,142 | $0 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 46 | 42 | 18 | N/A | N/A |
| Other Financing Activity | 36,077 | -3 | -1,643 | 70,704 | 0 |
| Financing Cash Flow | $36,123 | $39 | $-1,625 | $70,704 | $0 |
| Beginning Cash Position | 45,161 | 45,161 | 45,161 | 2,338 | 0 |
| End Cash Position | 89,317 | 21,290 | 31,828 | 45,161 | 0 |
| Net Cash Flow | $44,156 | $-23,871 | $-13,333 | $42,823 | $0 |
| Free Cash Flow | |||||
| Operating Cash Flow | 191,561 | -23,276 | -11,458 | -25,739 | 0 |
| Capital Expenditure | -1,254 | -634 | -250 | N/A | N/A |
| Free Cash Flow | 190,307 | -23,910 | -11,708 | -25,739 | 0 |